Twelve-month treatment success: 56% with PFA vs 30% with drugs.
PFA can be first therapy in this setting. It is not automatic. Nearly half still had recorded recurrence and need a plan — stroke risk, sleep apnea, blood pressure, and follow-up stay in the same practice.
This is a rhythm-efficacy trial, not a 5-year stroke/death trial.